UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039960
Receipt number R000045561
Scientific Title the effects of supplemental oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis
Date of disclosure of the study information 2020/03/27
Last modified on 2022/04/19 09:17:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

the effects of supplemental oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Acronym

the effects of supplemental oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Scientific Title

the effects of supplemental oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Scientific Title:Acronym

the effects of supplemental oxygen therapy during exercise training in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis

Region

Japan


Condition

Condition

chronic obstructive pulmonary disease

Classification by specialty

Pneumology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this meta-analysis is to elucidate whether supplemental oxygen therapy during exercise traning has efficacy in patients with on chronic obstructive pulmonary disease (COPD).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

6-minute walking distance,
shuttle walking distance

Key secondary outcomes

Borg scale
maximum work rate of exercise training


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with chronic obstructive pulmonary disease

Key exclusion criteria

none

Target sample size



Research contact person

Name of lead principal investigator

1st name Shohei
Middle name
Last name Kawachi

Organization

Shinshu University

Division name

Graduate school of medicine science and technology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto sity, Nagano, Japan

TEL

0263372393

Email

18hm205e@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Shohei
Middle name
Last name Kawachi

Organization

Shinshu University

Division name

Graduate school of medicine science and technology

Zip code

390-8621

Address

3-1-1, Asahi, Matsumoto sity, Nagano, Japan

TEL

0263-37-2393

Homepage URL


Email

18hm205e@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu university

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

None

Address

None

Tel

0263-37-2572

Email

mdrinri@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 03 Month 01 Day

Date of IRB


Anticipated trial start date

2020 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A systematic search of the literature is conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) Statement. We search for studies with inceptions up to 3 2020 in the following electronic databases: Cochrane Central Register of Controlled Trials (CEN-TRAL), MEDLINE, and EMBASE. The search was conducted using terms 'COPD', 'supplemental','oxygen therapy'. Hand search is taken for additional eligible studies. No language restrictions are applied.
We inclued all randomized controlled trials (RCTs) that evaluated the efficacy of combined exercise training and oxygen therapy with COPD.
Studies eligible for inclusion will meet all of the following criteria: (1) study design is an RCT; (2) study involve patients with confirmed COPD; (3) study compare the exercise trainig combined oxygen therapy with placebo gas or no oxygen therapy ; (4) study reported on at least one of the outcome measures.

SK and SY independently assess the quality of each study with the risk of bias tool in the Cochrane Handbook for Systematic Reviews of Interventions.
Participants are divided into two groups; combined exercise training with oxygen therapy and control group including placebo gas or no oxygen therapy. Duration and intensity are not limited.


Management information

Registered date

2020 Year 03 Month 27 Day

Last modified on

2022 Year 04 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045561


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name